In this Issue
Making the most of today's information and technology and looking ahead to tomorrow.
CHIEF MEDICAL EDITOR’S PAGE
By Steven D. Vold, MD
By Sunju Park, MD, and Assumpta Madu, MD, PharmD, MBA
CLINICIAN SCIENTIST’S CORNER
By Arthur J. Sit, SM, MD
The cost-utility analysis associated with glaucoma therapy.
By Gary C. Brown, MD, MBA; Joshua D. Stein, MD, MSc, MS; Melissa M. Brown, MD, MN, MBA; Richard P. Wilson, MD; and George L. Spaeth, MD
Research on the effects of space flight on the ocular system may help reveal if cerebrospinal fluid pressure plays a role in the development of glaucoma and idiopathic intracranial hypertension.
By John P. Berdahl, MD
By Sonya Babar Shah, MD, and Michael Pro, MD
By Steven Kymes, PhD, and Leon W. Herndon, MD
COVER STORIES: OPTIMIZING 24-HOUR GLAUCOMA CARE
By Yvonne N. Covin, MD; Daniel Laroche, MD; and Mildred M. G. Olivier, MD
This technology will lead to more personalized care for patients.
By Robert Chang, MD
This concept is evolving as the databases of large clinical trials are analyzed.
By Paul F. Palmberg, MD, PhD
Many glaucoma experts agree that IOP variation is important to evaluating and managing patients with glaucoma.
By Sanjay Asrani, MD
Tools to meet the challenge.
By Gail F. Schwartz, MD
Many products are in research and development, but there are numerous challenges.
By Gary D. Novack, PhD
Advances in technology make this option an attractive alternative or adjunct to medical therapy.
By Jason Bacharach, MD
The future of this intervention likely depends on the development of devices that communicate between the anterior chamber and the episcleral space.
By Michael Stiles, MD
Less surgery may be more.
By Robert Marquis, MD, PhD
Research suggests that many issues other than IOP may play a role in the pathophysiology of glaucoma.
By Shan Lin, MD
INDUSTRY NEWS AND INNOVATIONS
Dr. Mattox describes the challenges of health care regulations and of windsurfing.